Top-News
Pharmazeutika USA

Eledon Pharmaceuticals Inc News

Aktie
WKN:  A2QL00 ISIN:  US28617K1016 US-Symbol:  ELDN
2,79 €
+0,20 €
+7,72%
22:36:44 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
13,78 Mio.
Marktkapitalisierung *
35,50 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 12.02.2024

Eledon Pharmaceuticals Inc News

31.05.22 - PR Newswire
Thinking about buying stock in TherapeuticsMD, AMC Entertainment, Yamana Gold, Eledon Pharmaceuticals, or New Oriental Education?
Thinking about buying stock in TherapeuticsMD, AMC Entertainment, Yamana Gold, Eledon Pharmaceuticals, or New Oriental Education? PR Newswire
15.09.20 - PR Newswire
Thinking about buying stock in Novus Therapeutics, Delta Air Lines, Sorrento Therapeutics, Carnival Corp, or Exela Technologies?
Thinking about buying stock in Novus Therapeutics, Delta Air Lines, Sorrento Therapeutics, Carnival Corp, or Exela Technologies? PR Newswire
14.05.20 - PR Newswire
Thinking about buying stock in Applied DNA Sciences, Novus Therapeutics, Riot Blockchain, Upwork, or Delta Air Lines?
Thinking about buying stock in Applied DNA Sciences, Novus Therapeutics, Riot Blockchain, Upwork, or Delta Air Lines? PR Newswire
21.11.17 - PR Newswire
Novus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference
Novus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference PR Newswire
08.11.17 - PR Newswire
Novus Therapeutics Reports Third Quarter 2017 Results
Novus Therapeutics Reports Third Quarter 2017 Results PR Newswire
08.11.17 - PR Newswire
Novus Therapeutics Reports Third Quarter 2017 Results
Novus Therapeutics Reports Third Quarter 2017 Results PR Newswire
06.11.17 - PR Newswire
Novus Therapeutics Announces the Promotion of Dr. Catherine Turkel to President
Novus Therapeutics Announces the Promotion of Dr. Catherine Turkel to President PR Newswire
09.08.17 - PR Newswire
Novus Therapeutics Reports Second Quarter 2017 Results
Novus Therapeutics Reports Second Quarter 2017 Results PR Newswire
09.08.17 - PR Newswire
Novus Therapeutics Reports Second Quarter 2017 Results
Novus Therapeutics Reports Second Quarter 2017 Results PR Newswire
10.07.17 - PR Newswire
Novus Therapeutics Announces Change in Management
Novus Therapeutics Announces Change in Management PR Newswire
10.07.17 - PR Newswire
Novus Therapeutics Announces Change in Management
Novus Therapeutics Announces Change in Management PR Newswire
12.06.17 - PR Newswire
Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
12.06.17 - PR Newswire
Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire

Newssuche

Videos

newspaper
08:55 Uhr +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »